apoptosis stimulators p21-deficient cells (Wyeth)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameapoptosis stimulators p21-deficient cells (Wyeth)
Drug Alias Namepyrimidine-based antiproliferatives (Wyeth)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApoptosis stimulants
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWyeth Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWyeth Llc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A